Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 386

Results For "RI"

10353 News Found

Eastman & Kolmar Korea join forces to deliver biodegradable beauty breakthroughs
R&D | January 28, 2026

Eastman & Kolmar Korea join forces to deliver biodegradable beauty breakthroughs

The collaboration will center on expanding access to Eastman’s Esmeri technology


Truvian Health bags FDA clearance for CBC on TruVerus System
Drug Approval | January 28, 2026

Truvian Health bags FDA clearance for CBC on TruVerus System

TruVerus is the only FDA cleared, multi-modal platform capable of delivering comprehensive routine testing from a single lithium heparin sample


Hongene Biotech bags Gates Foundation grant to boost global mRNA vaccine access
News | January 28, 2026

Hongene Biotech bags Gates Foundation grant to boost global mRNA vaccine access

Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment


Parse Biosciences unveils integrated immune profiling in Trailmaker Platform
News | January 28, 2026

Parse Biosciences unveils integrated immune profiling in Trailmaker Platform

The new functionality complements Parse’s existing Evercode immune products


EU green light to IntraBio’s AQNEURSA for rare neurological disease Niemann-Pick Type C
News | January 28, 2026

EU green light to IntraBio’s AQNEURSA for rare neurological disease Niemann-Pick Type C

The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients


Cipla reports consolidated PAT of Rs. 675.80 Cr
News | January 24, 2026

Cipla reports consolidated PAT of Rs. 675.80 Cr

Cipla has reported total income of Rs. 7,280.82 crore during the period ended December 31, 2025


Laurus Labs reports consolidated Q3 net profit of Rs. 251.66 Cr
News | January 24, 2026

Laurus Labs reports consolidated Q3 net profit of Rs. 251.66 Cr

Laurus Labs has reported total income of Rs. 1,784.05 crore during the period ended December 31, 2025


Jagsonpal Pharmaceuticals posts Q3 FY26 profit at Rs. 10.95 Cr
News | January 24, 2026

Jagsonpal Pharmaceuticals posts Q3 FY26 profit at Rs. 10.95 Cr

Jagsonpal Pharmaceuticals has reported total income of Rs. 75.92 crore during the period ended December 31, 2025


Yugap Wellness bolsters scientific leadership with Dr Satish Singh appointment
People | January 24, 2026

Yugap Wellness bolsters scientific leadership with Dr Satish Singh appointment

A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods